Program

CME Info Disclosures Webcast Speaker Services Future Annual Meetings

Plenary

Practice Management Welcoming Reception Walk. Run. Win. Exhibit Hall Events Guest Tours Discounted Attraction Tickets Satellite Symposia Program Industry Scientific Updates

Interested in Exhibiting? Already an Exhibitor Floor Plan/Exhibitor List Marketing and Promotion Contacts

Visa Information Hotel Services Air Ground Travel About Orlando

Abstracts Presented at 2008 Meeting Search 2007 Abstracts Past Abstracts '04-'06 Program Abstract Book

On-site Registration Hours Individual Registration Group Registration Cancellations

Plenary

Late Breaking Science Forum
Tuesday, May 20
1:00 - 2:30 p.m.
Orange County Convention Center
Rooms W207A-B-C

The 2008 Late Breaking Science Forum, a new addition to our Annual Meeting agenda, was developed to showcase the results of clinical trials and other important research findings that were completed and submitted for consideration after the general deadline for submission of abstracts.

This year's Late Breaking Science Forum will include presentations of scientific discovery in the areas of prostate cancer, benign prostatic hyperplasia and the treatment of overactive bladder.

We believe that these presentations exemplify the best of late breaking research. These projects are innovative, exciting and will be of interest and impact to the clinical practice communities.

Moderators: Carl A. Olsson, M.D. and James L. Mohler, M.D.

Presentation Schedule
1:00 - 1:10 p.m.		Adjuvant Radiotherapy for pT3 Prostate Cancer: Results of a Randomized, Prospective Clinical Trial - 2008 Update Gregory P. Swanson, M.D.
1:10 - 1:20 p.m.		New Findings from the PCPT: Evidence that Finasteride Significantly Reduced Prostate Cancer Risk Across Multiple Gleason Scores, including the Most Frequently Detected Types of Clinically Significant Cancers (Gleason Scores 6 and 7) Steven A. Kaplan, M.D.
1:20 - 1:30 p.m.		Degarelix in a 12-Month Randomized, open-Label, Parallel-Group Phase III Study in Prostate Cancer Patients Laurence Klotz, M.D.
1:30 - 1:40 p.m.		Tadalafil Administered Once a Day in the Treatment of Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH): A Dose Finding Study Claus G. Roehrborn, M.D.
1:40 - 1:50 p.m.		A Randomized Multicenter Study Comparing Percutaneous Tibial Nerve Stimulation with Pharmaceutical Therapy for the Treatment of Overactive Bladder Kenneth M. Peters, M.D.
1:50 - 2:00 p.m.		NIDDK's New Strategic Vision for Benign Prostate Research Chris Mullins, Ph.D.
2:00 - 2:10 p.m.		A Sequential Treatment Approach to Myoinvasive Urothelial Cancer: A Phase II Southwest Oncology Group Trial (SO219) of Neoadjuvant Paclitaxel, Carboplatin and Gemcitabine Ralph W. deVere White, M.D.
2:10 - 2:20 p.m.		Safety, Efficacy and Pharmacokinetics of Testosterone, Undecanoate Long-Acting Injection of Hypogonadism: Results of a Phase III Clinical Trial Abraham Morgentaler, M.D.
2:20 - 2 :30 p.m.		ISSM Definition of Premature Ejaculation Ira D. Sharlip, M.D.


	© 2008 American Urological Association. All Rights Reserved.